The Titan Biotech Limited has informed about Newspaper publications of Audited Financial Results for the quarter and year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Limited has informed BSE that copies of its Audited Financial Results for the quarter and year ended 31 March 2025 have been published in two newspapers — Financial Express (English) and Naya India (Hindi) — on 31 May 2025. This publication is being done as required under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also confirmed that this intimation and the newspaper copies are available on its website at www.titanbiotechltd.com. The filing is signed by Charanjit Singh, Company Secretary & Compliance Officer. No actual financial figures are disclosed in this particular filing — it is purely a compliance-related newspaper publication notice.
This is a routine regulatory disclosure with no direct impact on shareholders or the stock price. It simply confirms that Titan Biotech's Q4 and FY25 audited results, which were already filed with BSE on 30 May 2025, have now also been published in newspapers as mandated by SEBI rules for wider public dissemination.